Skip to product information
1 of 1

FDA Additional Information (AI) Response

FDA Additional Information (AI) Response

Regular price Rs.728,659.00 PKR
Regular price Sale price Rs.728,659.00 PKR
Sale Sold out

+ 20% VAT Per Product Added On Checkout

Have Questions?

Speak with our compliance experts.

Connect Now
Quantity
Secure Payment
24–72h Delivery
100% Confidential
Expert Support
View full details

FDA Additional Information (AI) Response Support for Medical Devices

Has the US Food and Drug Administration (FDA) requested additional information about your medical device submission? The FDA Additional Information (AI) Response service from Cosmetic Compliance Nest helps medical device businesses review FDA questions, organise supporting documentation, and prepare structured responses to outstanding regulatory concerns.

An FDA Additional Information request may require clarification, further documentation, revised labelling, additional technical evidence, or explanations relating to a medical device submission. Responding effectively requires a clear understanding of each FDA question, the available supporting evidence, and the applicable submission requirements.

Our service helps you assess the request, identify the information needed to address individual questions, and prepare a response package based on the evidence and documentation supplied by your organisation.

What Is an FDA Additional Information (AI) Request?

An Additional Information (AI) request is a request from the FDA for further information or clarification during the review of a medical device submission. The exact terminology, process, and response requirements depend on the submission type and the FDA communication received.

For example, a 510(k) submission may receive questions concerning substantial equivalence, intended use, device characteristics, performance testing, biocompatibility, sterilisation, software, or labelling. The questions raised will depend on the device and the evidence already provided.

Each request should be reviewed carefully so that the response addresses the specific question, references appropriate supporting evidence, and avoids unsupported statements or inconsistencies with the original submission.

What Does Our FDA AI Response Service Cover?

  • FDA Request Review: Review the FDA communication and identify the individual questions, requested documents, and stated response requirements.
  • Question-by-Question Assessment: Organise each question into a structured response plan to help ensure that the requested points are addressed.
  • Documentation Gap Identification: Identify missing information, unclear explanations, and potential evidence gaps based on the supplied documents.
  • Technical Documentation Review: Review relevant device specifications, testing reports, technical files, and other supporting information within the agreed scope.
  • 510(k) Substantial Equivalence Support: Where applicable, help organise explanations and supporting evidence related to the device comparison and substantial equivalence rationale.
  • Testing and Performance Evidence: Review available evidence relating to performance, bench testing, biocompatibility, sterilisation, software, or other topics raised by the FDA.
  • Labelling and IFU Review: Assess relevant proposed label or Instructions for Use changes where they relate to the FDA's questions.
  • Draft Response Preparation: Help prepare clear, organised draft responses that reference the available supporting documentation.
  • Response Consistency Check: Review the draft responses for consistency with the supplied evidence and other relevant submission materials.
  • Supporting Document Organisation: Help organise relevant attachments, revised documents, and evidence references according to the agreed deliverables.

Testing, new studies, laboratory work, engineering changes, and the creation of new technical evidence are not automatically included in a response-preparation service. Any additional work must be assessed and agreed separately.

Who Should Consider This Service?

  • Medical device manufacturers who have received an FDA request for additional information.
  • Businesses responding to questions concerning a 510(k) premarket notification.
  • Foreign manufacturers preparing responses for medical devices intended for the US market.
  • Companies needing help organising technical evidence and regulatory documentation.
  • Businesses responding to questions about device performance, labelling, biocompatibility, sterilisation, or software.
  • Organisations reviewing the completeness and consistency of a proposed FDA response.
  • Medical device businesses seeking support with a response strategy before submitting further information to the FDA.

Our FDA AI Response Process

  1. Initial Assessment: Review the FDA communication, submission type, relevant deadlines, and available documentation.
  2. Request Breakdown: Separate the FDA's questions into individual items and clarify what information each question appears to require.
  3. Evidence Review: Examine the technical reports, device records, labelling, and other evidence supplied by your organisation.
  4. Response Planning: Identify the available evidence, missing information, and any issues that may require input from your technical or regulatory team.
  5. Drafting Responses: Prepare structured draft responses that directly address the questions and refer to relevant supporting evidence.
  6. Document Review: Check the draft response package for clarity, organisation, and consistency with the supplied documentation.
  7. Finalisation Support: Incorporate agreed revisions and organise the response materials for the client's review and submission.

Benefits of Professional FDA AI Response Support

  • Structured Responses: Organise the response around the FDA's individual questions and requests.
  • Clearer Technical Explanations: Present relevant information in a clear and consistent format based on the evidence available.
  • Better Documentation Organisation: Identify relevant reports, records, and supporting documents for each response.
  • Early Gap Identification: Identify questions that may require additional technical evidence or specialist input.
  • Improved Consistency: Check proposed responses against the supplied submission materials to help identify contradictions or unsupported statements.
  • Deadline Awareness: Include the FDA's stated response deadline in the planning process and identify time-sensitive documentation needs.

Documents and Information You May Need

Depending on your submission and the questions raised by the FDA, the following information may be requested:

  • The complete FDA Additional Information request or official correspondence.
  • The original submission and relevant submission sections.
  • Device description, intended use, and indications for use.
  • Device specifications and relevant technical documentation.
  • Bench testing and performance testing reports, where applicable.
  • Biocompatibility, sterilisation, or other supporting reports, where relevant.
  • Software documentation, risk analysis, or cybersecurity documentation, where applicable.
  • Proposed labels, packaging information, and Instructions for Use.
  • Substantial equivalence comparisons and predicate device information, where applicable.
  • Previous FDA correspondence and any response drafts already prepared.

The documents required will depend on the specific FDA questions. Not every item applies to every device or submission.

Important Considerations When Responding to FDA Questions

FDA response preparation should begin with a careful review of the official request, including the submission type, requested information, response format, and applicable deadline. Each question should be addressed using relevant evidence and accurate device information.

If the FDA identifies a gap that cannot be resolved using existing records, additional testing, technical investigation, revised documentation, or specialist input may be necessary. These activities should be identified early so that their feasibility and timing can be assessed.

For 510(k) submissions, the response should remain consistent with the device description, intended use, technological characteristics, and substantial equivalence rationale. The applicable submission pathway and FDA communication should guide the response strategy.

Frequently Asked Questions About FDA AI Response Support

Visit our dedicated Frequently Asked Questions page for more information about FDA Additional Information requests, response documentation, 510(k) submissions, supporting evidence, and regulatory response preparation.

Prepare Your FDA Additional Information Response

Respond to FDA questions with a structured, evidence-based approach. The FDA Additional Information (AI) Response service from Cosmetic Compliance Nest helps medical device businesses organise regulatory questions, prepare draft responses, and review supporting documentation in line with the agreed scope of work.

Important Disclaimer

Cosmetic Compliance Nest provides independent regulatory consultancy and documentation support and is not affiliated with or endorsed by the US Food and Drug Administration (FDA). The service supports the preparation and review of responses using information supplied by the client. It does not guarantee FDA clearance, approval, acceptance of a response, or a favourable regulatory outcome. The client remains responsible for the accuracy of technical information, the adequacy of supporting evidence, final review and authorisation of submissions, and compliance with applicable regulatory requirements. New testing, laboratory studies, engineering changes, formal submission fees, and additional regulatory work are excluded unless expressly included in the agreed service terms.


It is a request for further information or clarification during the FDA's review of a medical device submission.


It can include reviewing the FDA request, organising questions, assessing supplied evidence, preparing draft responses, and reviewing supporting documents according to the agreed scope.


Yes. Support can be provided for relevant 510(k) questions, including substantial equivalence, device performance, and labelling, depending on the agreed scope.


Provide the official FDA communication, the relevant submission documents, available technical reports, device labelling, and previous correspondence.


We can help identify evidence gaps and discuss possible next steps. Additional testing, studies, or technical investigations require separate assessment.


Laboratory testing is not included unless explicitly specified in the agreed service package.


No. The FDA independently evaluates the submission and response. No particular regulatory outcome can be guaranteed.